On this episode of Tech Nation, Moira speaks with MIT professor DAVID MINDELL co-founder of Humatics Corporation about his book “Our Robots, Ourselves: Robotics and the Myths of Autonomy.” He's here to discuss what robots are capable of and what we might want to rethink whether it's driverless cars or predator drones. He's also out to dispel the “persistent misconceptions about robots.”

Then on BioTech Nation, what biotech has been working on to treat rare diseases that primarily effect young boys including hemophilia and Duchene Muscular Dystrophy.

First up is PAUL PERRAULT, CEO of CSL Behring, a 100-year old biotech company founded by the Australian government to fight the Spanish flu, today they focus on rare diseases in plasma and recombinant proteins such as hemophilia.

Then Moira talks to SHANE KOVACS, CFO of PTC Therapeutics about their progress on a treatment for Duchene Muscular Dystrophy.